Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.1%

6 terminated/withdrawn out of 98 trials

Success Rate

87.8%

+1.3% vs industry average

Late-Stage Pipeline

17%

17 trials in Phase 3/4

Results Transparency

0 of 43 completed trials have results

Key Signals

29 recruiting

Enrollment Performance

Analytics

N/A

39(54.9%)

Phase 2

15(21.1%)

Phase 4

11(15.5%)

Phase 3

6(8.5%)

71Total

N/A(39)

Phase 2(15)

Phase 4(11)

Phase 3(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (98)

Showing 20 of 98 trials

NCT06170944Not ApplicableRecruiting

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke

Role: lead

NCT06940128Not ApplicableRecruiting

Direct Ischemic Conditioning for Endovascular Recanalization for Anterior Large Vessel Occlusion (DICER-aLVO)

Role: lead

NCT06763458Not ApplicableRecruiting

Balloon Angioplasty for Minor Unstable Stroke With IntraCranial Atherosclerosis Stenosis (BAMUS-ICAS)

Role: lead

NCT06931535Not ApplicableRecruiting

Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke

Role: lead

NCT03753555Phase 4Recruiting

The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

Role: lead

NCT03571763Recruiting

The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

Role: lead

NCT06010641Not ApplicableRecruiting

Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)

Role: lead

NCT07550296Phase 2Not Yet Recruiting

Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase

Role: lead

NCT05128513Not ApplicableSuspended

Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke

Role: lead

NCT07375966Phase 2Recruiting

Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

Role: lead

NCT07248722Not ApplicableEnrolling By Invitation

Pantoprazole After Prophylactic Endoscopic Variceal Treatment

Role: lead

NCT07375953Phase 2Recruiting

Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)

Role: lead

NCT06242405Not ApplicableCompleted

Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD

Role: lead

NCT07294885Not ApplicableRecruiting

Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease

Role: lead

NCT07462546Not ApplicableRecruiting

Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)

Role: lead

NCT07412249Not ApplicableRecruiting

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Role: lead

NCT07388420Not ApplicableRecruiting

Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis

Role: lead

NCT07283159Phase 2Recruiting

Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)

Role: lead

NCT07344610Recruiting

Effects of Short-term Intensive Statin Therapy on Lipid Levels

Role: lead

NCT06410443Not ApplicableRecruiting

Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury

Role: lead